Inventor · disambiguated record
Rifat Pamukcu
Also filed as: PAMUKCU RIFAT
75 granted patents·22 pending applications·1,869 citations·filing 1992–2018
99Inventor score
Top patents by PatentIndex Score
97 records- 0196US6348032B1Method of inhibiting neoplastic cells with benzimidazole derivativesCELL PATHWAYS INC·Filed 1998·Granted Feb 19, 2002·117 cites·2 claims
- 0294US6046206AMethod of treating a patient having a precancerous lesions with amide quinazoline derivativesCELL PATHWAYS INC·Filed 1997·Granted Apr 4, 2000·150 cites·10 claims
- 0393US5948911AMethod for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivativesCELL PATHWAYS INC·Filed 1998·Granted Sep 7, 1999·69 cites·19 claims
- 0492US6358992B1Method of inhibiting neoplastic cells with indole derivativesCELL PATHWAYS INC·Filed 1999·Granted Mar 19, 2002·125 cites·14 claims
- 0592US6200980B1Method of treating a patient having precancerous lesions with phenyl purinone derivativesCELL PATHWAYS INC·Filed 1997·Granted Mar 13, 2001·60 cites·8 claims
- 0691US6380206B1Method of inhibiting neoplastic cells with 4,5-diaminopyrimidine derivativesCELL PATHWAYS INC·Filed 2001·Granted Apr 30, 2002·35 cites·6 claims
- 0791US6133271AMethod for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivativesCELL PATHWAYS INC·Filed 1998·Granted Oct 17, 2000·92 cites·12 claims
- 0891US5401774AMethod for treating patients with precancerous lesions by administering substituted sulfonyl idenyl acetic and propionic acids and esters to patients with lesions sensitive to such compoundsUNIV ARIZONA·Filed 1992·Granted Mar 28, 1995·122 cites·1 claims
- 0990US6369092B1Method for treating neoplasia by exposure to substituted benzimidazole derivativesCELL PATHWAYS INC·Filed 2001·Granted Apr 9, 2002·32 cites·3 claims
- 1090US6235782B1Method for treating a patient with neoplasia by treatment with a platinum coordination complexFiled 1998·Granted May 22, 2001·65 cites·10 claims
- 1187US6166053ASubstituted condensation products of N-benzyl-3-idenylacetamides with heterocyclic aldehydes for neoplasiaCELL PATHWAYS INC·Filed 2000·Granted Dec 26, 2000·14 cites·2 claims
- 1287US5696159ALactone compounds for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 1994·Granted Dec 9, 1997·35 cites·18 claims
- 1386US6486158B1[4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasiaCELL PATHWAYS INC·Filed 2001·Granted Nov 26, 2002·17 cites·33 claims
- 1486US6211177B1Method for treating neoplasia by exposure to substituted 2-aryl-benzimidazole derivativesCELL PATHWAYS INC·Filed 1998·Granted Apr 3, 2001·86 cites·6 claims
- 1583US6420410B1Method for treating neoplasia by exposure to N,N′-substituted benzimidazol-2-onesCELL PATHWAYS INC·Filed 2000·Granted Jul 16, 2002·17 cites·7 claims
- 1682US6403831B1Substituted benzylidene indenyl formamides, acetamides and propionamidesCELL PATHWAYS INC·Filed 2000·Granted Jun 11, 2002·13 cites·1 claims
- 1782US6180629B1[4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasiaCELL PATHWAYS INC·Filed 1998·Granted Jan 30, 2001·28 cites·24 claims
- 1880US6410584B1Method for inhibiting neoplastic cells with indole derivativesCELL PATHWAYS INC·Filed 1998·Granted Jun 25, 2002·46 cites·2 claims
- 1980US5858694AMethod for identifying compounds for inhibition of cancerous lesionsCELL PATHWAYS INC·Filed 1997·Granted Jan 12, 1999·60 cites·26 claims
- 2079US6300346B1Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 2000·Granted Oct 9, 2001·7 cites·16 claims
- 2178US7115647B2Method of inhibiting neoplastic cells with indole derivativesOSI PHARM INC·Filed 2002·Granted Oct 3, 2006·6 cites·3 claims
- 2278US6262059B1Method of treating a patient having precancerous lesions with quinazoline derivativesCELL PATHWAYS INC·Filed 1998·Granted Jul 17, 2001·44 cites·19 claims
- 2377US6359002B2Method for treating a patient with neoplasia by treatment with a platinum coordination complexCELL PATHWAYS INC·Filed 2001·Granted Mar 19, 2002·4 cites·1 claims
- 2476US5990117AMethod for inhibiting neoplastic cells and related conditions by exposure to quinazoline derivativesCELL PATHWAYS INC·Filed 1998·Granted Nov 23, 1999·43 cites·10 claims
- 2576US5965619AMethod for treating patients having precancerous lesions with substituted indene derivativesCELL PATHWAYS INC·Filed 1997·Granted Oct 12, 1999·47 cites·29 claims
- 2675US6869944B2Method for treating a patient with neoplasia by treatment with a platinum coordination complexOSI PHARM INC·Filed 2002·Granted Mar 22, 2005·3 cites·3 claims
- 2774US6063818ASubstituted benzylidene indenyl formamides, acetamides and propionamidesCELL PATHWAYS INC·Filed 1997·Granted May 16, 2000·32 cites·47 claims
- 2873US6555547B1Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivativeCELL PATHWAYS INC·Filed 2000·Granted Apr 29, 2003·5 cites·17 claims
- 2972US6391885B1Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivativesCELL PATHWAYS INC·Filed 2000·Granted May 21, 2002·2 cites·4 claims
- 3071US5948779ASubstituted condensation products of n-benzyl-3-indenyl acetamides with heterocyclic aldehydesCELL PATHWAYS INC·Filed 1997·Granted Sep 7, 1999·13 cites·77 claims
- 3170US6365627B2Method for treating a patient with neoplasia by treatment with a paclitaxel derivativeCELL PATHWAYS INC·Filed 2001·Granted Apr 2, 2002·1 cites·1 claims
- 3270US6066634ASubstituted condensation products of N-benzyl-3-indenylacetamides heterocyclic aldehydes for neoplasiaCELL PATHWAYS INC·Filed 1998·Granted May 23, 2000·12 cites·28 claims
- 3369US6472420B2Method for treating a patient with neoplasia by treatment with a paclitaxel derivativeCELL PATHWAYS INC·Filed 2002·Granted Oct 29, 2002·1 cites·3 claims
- 3468US5874440AMethod of treating a patient having precancerous lesions with phenyl pyrimidinone derivativesCELL PATHWAYS INC·Filed 1995·Granted Feb 23, 1999·27 cites·16 claims
- 3567US6500610B1Methods for identifying compounds for inhibiting of neoplastic lesions, and pharmaceutical compositions containing such compoundsCELL PATHWAYS INC·Filed 1999·Granted Dec 31, 2002·22 cites·12 claims
- 3667US6232312B1Method for treating patient having precancerous lesions with a combination of pyrimidopyrimidine derivatives and esters and amides of substituted indenyl acetic acidesCELL PATHWAYS INC·Filed 1998·Granted May 15, 2001·31 cites·14 claims
- 3766US6071934AIndenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 1997·Granted Jun 6, 2000·25 cites·4 claims
- 3866US6028116ASubstituted condensation products of 1H-indenyl-hydroxyalkanes with aldehydes for neoplasiaCELL PATHWAYS INC·Filed 1998·Granted Feb 22, 2000·29 cites·52 claims
- 3966US5852035AMethod for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-aminesCELL PATHWAYS INC·Filed 1997·Granted Dec 22, 1998·28 cites·15 claims
- 4065US5942520AMethod for inhibiting neoplastic cells by exposure to substituted N-cycloalkylmethyl-1-H-pyrazolo (3,4-B) quinolone-4 aminesCELL PATHWAYS INC·Filed 1998·Granted Aug 24, 1999·27 cites·15 claims
- 4164US6121321ASubstituted methoxy benzylidene indenyl acetic and propionic acids for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 1996·Granted Sep 19, 2000·26 cites·23 claims
- 4264US5643959AMethod for treating patients with precancerous lesions by administering substituted sulfonyl indenyl acetic and propionic acids and esters thereofCELL PATHWAYS INC·Filed 1994·Granted Jul 1, 1997·17 cites·11 claims
- 4362US6486155B1Method of inhibiting neoplastic cells with isoquinoline derivativesCELL PATHWAYS INC·Filed 1998·Granted Nov 26, 2002·21 cites·2 claims
- 4462US2003190686A1Methods for identifying compounds for inhibition of neoplastic lesions, and pharmacetical compositions containing such compoundsFiled 2002·Application pending·0 cites
- 4561US6034099AMethod for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-onesCELL PATHWAYS INC·Filed 1998·Granted Mar 7, 2000·21 cites·9 claims
- 4660US6200771B1Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasiaCELL PATHWAYS INC·Filed 1998·Granted Mar 13, 2001·18 cites·13 claims
- 4759US6235776B1Method for treating a patient with neoplasia by treatment with a paclitaxel derivativeCELL PATHWAYS INC·Filed 1998·Granted May 22, 2001·12 cites·10 claims
- 4858US2003004093A1Method for identifying compounds for inhibition of neoplastic lesionsFiled 2002·Application pending·0 cites
- 4957US6160003A1,3,6-trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasiaCELL PATHWAYS INC·Filed 1999·Granted Dec 12, 2000·5 cites·18 claims
- 5057US2003220252A1Method for treating a patient with neoplasia by treatment with a gonadotropin releasing hormone analogFiled 2003·Application pending·0 cites
Showing the top 50 of 97 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Rifat Pamukcu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →